印度人接种新冠疫苗后心律失常评估的见解。
Insights from assessment for arrhythmia after CoViD-19 vaccination among Indians.
作者信息
Sunita S, Negi Madhu Bala, Lal Moti, Kumar Chandan, Kumar Manish
机构信息
Department of Physiology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
Department of Medicine, ABVIMS, New Delhi, India.
出版信息
Bioinformation. 2024 May 31;20(5):430-433. doi: 10.6026/973206300200430. eCollection 2024.
Post-vaccination myocarditis is usually moderate and transient, recovering quickly with conservative treatment. Therefore, it is of interest to assess for arrhythmia after CoViD-19 vaccination among Indians. We looked for ECG abnormalities in a small cohort of 50 participants after 52 weeks after receiving the Oxford/AstraZeneca CoViD-19 vaccination. Data shows that post-vaccination myocarditis is typically mild and transient, with most cases resolving swiftly through conservative management. Thus, it is unlikely that this vaccine will induce severe arrhythmias or life-threatening cardiac events in the general population.
接种疫苗后发生的心肌炎通常症状中等且为一过性，通过保守治疗可迅速恢复。因此，评估印度人群接种新冠疫苗后发生心律失常的情况很有意义。我们在50名参与者的小队列中，观察了接种牛津/阿斯利康新冠疫苗52周后的心电图异常情况。数据显示，接种疫苗后发生的心肌炎通常症状轻微且为一过性，大多数病例通过保守治疗可迅速缓解。因此，这种疫苗在普通人群中不太可能诱发严重心律失常或危及生命的心脏事件。
Zotero 插件